Abstract
Increased injury deaths have been reported among treatment groups in cholesterol lowering trials, leading to speculation that lipid lowering may result in behavioral disorders. We investigated this in 319 men enrolled in a 2-year trial of lipid lowering diets who completed measures of depression and hostility at entry and 24 months later. Mean Beck Depression Inventory (BDI) scores were lower after 24 months (3.8 versus 3.3,p<0.05) and Symptom Checklist 90-Revised (SCL-90) depression and hostility scores were unchanged. After adjustment for potential confounding, 24-month hostility and BDI scores were unrelated to lipid changes. A small inverse association of borderline statistical significance (B=0.034,p=0.08) was noted between 24-month SCL-90 depression scores and lipid changes. Lipid lowering diets had no significant adverse effect on psychological function and are consistent with current dietary recommendations.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Criqui MH: Cholesterol, primary and secondary prevention, and all-cause mortality.Annals of Internal Medicine. 1991,115:973–976.
Oliver MF: Reducing cholesterol does not reduce mortality.Journal of the American College of Cardiology. 1988,12:814–817.
Oliver MF: Doubts about preventing coronary heart disease.British Medical Journal. 1992,304:393–394.
Frick MH, Elo O, Haapa K, et al: Primary prevention trial with gemfibrozil in middle-aged men with dyslipidemia.New England Journal of Medicine. 1987,317:1237–1245.
Lipid Research Clinics Program: The Lipid Research Clinics Coronary Primary Prevention Trial results, I: Reduction in incidence of coronary heart disease.Journal of the American Medical Association. 1984,251:351–364.
Wysowski DK, Gross TP: Deaths due to accidents and violence in two recent trials of cholesterol-lowering drugs.Archives of Internal Medicine. 1990,150:2169–2172.
Muldoon MF, Manuck SB, Matthews KA: Lowering cholesterol concentrations and mortality: A quantitative review of primary prevention trials.British Medical Journal. 1990,301:309–314.
Smith GD, Pekkanen J: Should there be a moratorium on the use of cholesterol lowering drugs?British Medical Journal. 1992,304:431–434.
Engelberg H: Low serum cholesterol and suicide.Lancet. 1992,339:727–729.
Mason RP, Herbette LG, Silverman DI: Can altering serum cholesterol affect neurologic function?Journal of Molecular and Cellular Cardiology. 1991,23:1339–1342.
Katz AM: Cholesterol and violent death.Journal of Molecular and Cellular Cardiology. 1991,23:1343–1344.
Virkkunen M: Serum cholesterol in antisocial personality.Neuropsychobiology. 1979,5:27–30.
Virkkunen M: Serum cholesterol levels in homicidal offenders.Neuropsychobiology. 1983,10:65–69.
Virkkunen M, Penttinen H: Serum cholesterol in aggressive conduct disorder: A preliminary study.Biological Psychiatry. 1984,19:435–439.
Morgan RE, Palinkas LA, Barrett-Connor EL, Wingard DL: Plasma cholesterol and depressive symptoms in older men.Lancet. 1993,341:75–79.
Gallerani M, Manfredini R, Caracciolo S, et al: Serum cholesterol concentrations in parasuicide.British Medical Journal. 1995,310: 1632–1636.
Freedman DS, Byers T, Barrett DH, et al: Plasma lipid levels and psychologic characteristics in men.American Journal of Epidemiology. 1995,141:507–517.
Brown SL, Salive ME, Harris TB, et al: Low cholesterol concentrations and severe depressive symptoms in elderly people.British Medical Journal. 1994,308:1328–1332.
Muldoon MF, Matthews KA, Wing RR: Serum cholesterol and depression in women.Circulation. 1994,89:6.
Weidner G, Connor SL, Hollis JF, Connor WE: Improvements in hostility, and depression in relation to dietary change and cholesterol lowering: The Family Heart Study.Annals of Internal Medicine. 1992,117:820–823.
Lewis B, Tikkanen MJ: Low blood cholesterol and mortality: Causality, consequence, and confounders.American Journal of Cardiology. 1994,73:80–85.
Muldoon MF, Manuck SB: Health through cholesterol reduction: Are there unforeseen risks?Annals of Behavioral Medicine. 1992,14:101–108.
Cummings P, Psaty BM: The association between cholesterol and death from injury.Annals of Internal Medicine. 1994,120:848–855.
Santiago JM, Dalen JE: Cholesterol and violent behavior.Archives of Internal Medicine. 1994,154:1317–1321.
Jacobs DR, Muldoon MF, Rastam L: Invited commentary: Low blood cholesterol, nonillness mortality, and other, nonatherosclerotic disease mortality: A search for causes and confounders.American Journal of Epidemiology. 1995,141:518–522.
Kaplan JR, Manuck SB, Shively C: The effects of fat and cholesterol on social behavior in monkeys.Psychosomatic Medicine. 1991,53:634–642.
Kaplan JR, Shively CA, Fontenot MB, et al: Demonstration of an association among dietary cholesterol, central serotonergic activity, and social behavior in monkeys.Psychosomatic Medicine. 1994,56:479–484.
Anderson IM, Parry-Billings M, Newsholme EA, Fairburn CG, Cowen PJ: Dieting reduces plasma tryptophan and alters brain 5-HT function in women.Psychological Medicine. 1990,20:785–791.
Golomb BA: Cholesterol and violence: Is there a connection?Annals of Internal Medicine. 1998,128:478–487.
Knopp RH, Walden CE, Retzlaff BM, et al: Long-term cholesterol lowering effects of four different fat restricted diets in hypercholesterolemic and combined hyperlipidemic (CHL) men: The Dietary Alternatives Study.Journal of the American Medical Association. 1997,278:1509–1515.
Walden CE, McCann BS, Retzlaff B, et al: Alternative fat-restricted diets for hypercholesterolemia and combined hyperlipidemia: Feasibility, design, subject recruitment, and baseline characteristics of the Dietary Alternatives Study.Journal of the American College of Nutrition. 1991,10:429–442.
Derogatis LR:SCL-90-R: Administration, Scoring, and Procedures Manual II. Towson, MD: Clinical Psychometric Research, 1992.
Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J: An inventory for measuring depression.Archives of General Psychiatry. 1961,4:561–571.
McCann BS, Retzlaff BM, Dowdy AA, Walden CE, Knopp RH: Promoting adherence to low-fat, low-cholesterol diets: Review and recommendations.Journal of the American Dietetic Association. 1990,90:1408–1417.
Beck AT:Depression: Clinical, Experimental, and Theoretical Aspects. New York: Harper & Row, 1967.
Oliver JM, Simmons ME: Depression as measured by the DSM-III and the Beck Depression Inventory in an unselected adult population.Journal of Consulting and Clinical Psychology. 1984,52:892–898.
Derogatis LR:SCL-90-R Version Manual-I. Baltimore, MD: Johns Hopkins University Press, 1977.
Derogatis LR:Clinical Psychopharmacology. Menlo Park, CA: Addison-Wesley, 1986.
Derogatis LR, Rickels K, Rock AF: The SCL-90 and the MMPI: A step in the validation of a new self-report scale.British Journal of Psychiatry. 1976,128:280–289.
Markovitz JH, Smith D, Raczynski JM, et al: Lack of relations of hostility, negative affect, and high-risk behavior with low plasma lipid levels in the Coronary Artery Risk Development in Young Adults Study.Archives of Internal Medicine. 1997,157:1953–1959.
McCann BS, Bovbjerg VE, Brief DJ, et al: Relationship of self-efficacy to cholesterol lowering and dietary change in hyperlipidemia.Annals of Behavioral Medicine. 1995,17:221–226.
Scandinavian Simvastatin Survival Study Group: Randomised trial of cholesterol lowering in 4,444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S).Lancet. 1994,344:1383–1389.
Shepherd J, Cobbe SM, Ford I, et al: Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia.New England Journal of Medicine. 1995,333:1301–1307.
Gould AL, Rossouw JE, Santanello NC, Heyse JF, Furberg CD: Cholesterol reduction yields clinical benefit: A new look at old data.Circulation. 1995,91:2274–2282.
The Expert Panel: Summary of the second report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II).Journal of the American Medical Association. 1993,269:3015–3023.
Author information
Authors and Affiliations
Additional information
Preparation of this manuscript was supported in part by NIH grant HL28891 from the National Heart, Lung, and Blood Institute and NIH grant DK35816 (Clinical Nutrition Research Unit).
About this article
Cite this article
Bovbjerg, V.E., McCann, B.S., Retzlaff, B.M. et al. Effect of cholesterol-lowering diets on indices of depression and hostility. ann. behav. med. 21, 98–101 (1999). https://doi.org/10.1007/BF02895039
Issue Date:
DOI: https://doi.org/10.1007/BF02895039